HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muñoz, B. Articles by West, S. K. Search for Related Content PubMed PubMed Citation Articles by Muñoz, B. Articles by West, S. K.

Antibiotic Dosage in Trachoma Control Programs: Height as a Surrogate for Weight in Children

¹From the Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; the ²London School of Hygiene and Tropical Medicine, London, United Kingdom; the ³Kilimanjaro Christian Medical College, Tumaini University, Moshi, Tanzania; the ⁴Huruma Hospital, Rombo, Tanzania; ⁵The Carter Center, Atlanta, Georgia; and the ⁶Medical Research Council Laboratories, Banjul, The Gambia.

PURPOSE. National programs for trachoma control are implementing mass treatment programs in which azithromycin is used as part of the control strategy. Dose is determined by weight, which can be difficult to determine in field conditions. The purposes of this study were to determine whether an accurate dose could be determined by using height as a surrogate for weight and whether a single model of height-based dosage would be applicable in more than one setting.

METHODS. Data on height, weight, age, and gender of 5558 children aged 6 months to15 years were obtained from Kongwa and Rombo, Tanzania; Malakal, Sudan; Jareng, The Gambia; and Daboya, Ghana. Models for predicting weight by measuring height were developed that incorporated country-specific parameters. Doses of azithromycin assumed suspension of 40 mg/mL and 250-mg tablets that could be halved. Tolerance limits were defined as 15 to 30 mg/kg.

RESULTS. A regression model, predicting log weight as a function of log height, was the best fit and explained 94% of the variance. In children less than 1 year of age or 60 cm in height, dose determined by weight was preferred. Dosage by height resulted in more than 97% of children receiving doses within the tolerance limits. Children aged 1 to 2 years were the group most likely to be over- or undermedicated, but this occurred in only 6% of this age group.

CONCLUSIONS. Height-based determination of dosage of azithromycin in trachoma control programs appears to be feasible, using the height-based schedule proposed. One model was adequate for all the countries in the study. Further expansion to other countries is warranted.

This article has been cited by other articles:

				E. S. West, B. Munoz, H. Mkocha, M. J. Holland, A. Aguirre, A. W. Solomon, R. Bailey, A. Foster, D. Mabey, and S. K. West Mass Treatment and the Effect on the Load of Chlamydia trachomatis Infection in a Trachoma-Hyperendemic Community Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 83 - 87. [Abstract] [Full Text] [PDF]

				S. K. WEST BLINDING TRACHOMA: PREVENTION WITH THE SAFE STRATEGY Am J Trop Med Hyg, November 1, 2003; 69(2007): 18 - 23. [Abstract] [Full Text] [PDF]

eLetters: